Sputum analysis by flow cytometry; an effective platform to analyze the lung environment

Area of Science:

• Oncology
• Pulmonology
• Biotechnology

Background:

• Low-dose computed tomography (LDCT) is standard for lung cancer screening but has limited specificity, leading to unnecessary procedures.
• There is a critical need for accurate diagnostic adjuncts to LDCT for lung cancer.
• Sputum analysis offers a non-invasive method to assess the lung environment.

Purpose of the Study:

• To evaluate the feasibility of using flow cytometry to analyze sputum for lung cancer diagnosis.
• To identify distinct cellular signatures in sputum that differentiate lung cancer patients from high-risk individuals.
• To establish a high-throughput, standardized platform for sputum-based lung cancer diagnostics.

Main Methods:

• Sputum samples were collected from smokers with confirmed lung cancer or at high risk.
• Dissociated sputum cells were analyzed using flow cytometry with specific cell markers and meso-tetra(4-carboxyphenyl) porphyrin (TCPP).
• Cell populations, viability, and fluorescence intensity were assessed to identify distinguishing characteristics.

Main Results:

• Reproducible cellular population signatures were identified in sputum samples.
• The study demonstrated the feasibility of a standardized, high-throughput flow cytometry platform for sputum analysis.
• Differences in cell characteristics and fluorescence were observed, suggesting potential for distinguishing cancer from high-risk samples.

Conclusions:

• Flow cytometry analysis of sputum is a feasible approach for lung cancer diagnosis.
• This method holds potential as an adjunct to LDCT, improving screening accuracy.
• Further research can refine this technique for clinical application in lung cancer detection.